Role of D-Dimer Test in COVID-19 Diagnostics

What is D-Dimer Test? What is the role of D-Dimer test in Covid-19 diagnosis? Why is the test done? Everything around this, that you should know, in this post and of course our doctors always there to help you. Just fill in your details in the form down below and we will answer all your questions for FREE!

What is D-Dimer?

D- dimer is a protein fragment that is produced when a blood clot dissolves in your body.

What is D-Dimer Test?

D-dimer Test is a blood test often used to measure and assess clot formation.D-Dimer level is tested using immunoturbidimetric assay with refence range of 0-0.50mg/L.

How D-Dimer test is conducted?

A health care professional will take a blood sample from a vein in your arm, using a small needle. After the needle is inserted, a small amount of blood will be collected into a test tube or vial. You may feel a little sting when the needle goes in or out. This usually takes less than five minutes.

What is the need to do this test?

The presence of D-dimer in the blood plasma, which has a half-life of roughly 8 hours until kidney clearance occurs, is often used as a clinical biomarker to identify thrombotic activity and therefore diagnose conditions like pulmonary embolism (PE), deep vein thrombosis (DVT), venous thromboembolism (VTE) and disseminated intravascular coagulation (DIC) and coronary artery disease.

What are the methods to quantify D-Dimer levels?

There are currently four major types of commercial assays that can be used to measure D-dimer levels, of which include whole blood analysis, enzyme-linked immunosorbent assay (ELISA), enzyme-linked immunofluorescence assay (ELFA) and Latex-enhanced immunoturbidimetric assay.

How D-Dimer Test is associated with Covid-19?

As Covid-19 patients has high risk of developing renal failure,venous blood clots and other complications associated with blood clots such as stroke.So elevated levels in D-Dimer test is used as a biomarker for disease severity.

What is the importance of identifying Covid-19 biomarkers?

It is estimated that COVID-19 patients will experience critical forms of this disease that progress to severe cases with respiratory distress syndrome, coagulation dysfunction, multiple organ failure, etc.Therefore, early identification of the severity is very important to the clinical diagnosis of and treatment for COVID-19.

Also Read: Deadly Coronavirus

For more information, you can visit IndiaTimes and hematology.org.

Share this:

Leave a Reply

Your email address will not be published. Required fields are marked *

Drop Your Queries
Recent
Social

Get In Touch

India

US & Canada